ID23184A - Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi - Google Patents

Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi

Info

Publication number
ID23184A
ID23184A IDW991444A ID991444A ID23184A ID 23184 A ID23184 A ID 23184A ID W991444 A IDW991444 A ID W991444A ID 991444 A ID991444 A ID 991444A ID 23184 A ID23184 A ID 23184A
Authority
ID
Indonesia
Prior art keywords
organoprotective
sales
activities
therapy
making
Prior art date
Application number
IDW991444A
Other languages
English (en)
Indonesian (id)
Inventor
Predrag Sikiric
Marijan Petek
Sven Seiwerth
Branko Turkovic
Zeljko Grabarevic
Ivo Rotkvic
Stjepan Mise
Marko Duvnjak
Ivan Udovicic
Original Assignee
Predrag Sikiric Cs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Predrag Sikiric Cs filed Critical Predrag Sikiric Cs
Publication of ID23184A publication Critical patent/ID23184A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IDW991444A 1997-05-23 1998-05-20 Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi ID23184A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97108384 1997-05-23

Publications (1)

Publication Number Publication Date
ID23184A true ID23184A (id) 2000-03-23

Family

ID=8226822

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991444A ID23184A (id) 1997-05-23 1998-05-20 Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi

Country Status (28)

Country Link
US (1) US6288028B1 (sr)
EP (1) EP0983300B1 (sr)
JP (1) JP3492381B2 (sr)
KR (1) KR100488038B1 (sr)
CN (1) CN1166683C (sr)
AR (1) AR011478A1 (sr)
AT (1) ATE277948T1 (sr)
AU (1) AU731317B2 (sr)
BG (1) BG64023B1 (sr)
BR (1) BR9809457B1 (sr)
CA (1) CA2290739C (sr)
CZ (1) CZ299423B6 (sr)
DE (1) DE69826653T2 (sr)
DK (1) DK0983300T3 (sr)
EA (1) EA002058B1 (sr)
ES (1) ES2229507T3 (sr)
HU (1) HU227800B1 (sr)
ID (1) ID23184A (sr)
IL (2) IL132884A0 (sr)
NO (1) NO321126B1 (sr)
NZ (1) NZ501323A (sr)
PL (1) PL193790B1 (sr)
PT (1) PT983300E (sr)
RS (1) RS49733B (sr)
SK (1) SK159599A3 (sr)
TR (1) TR199902866T2 (sr)
UA (1) UA61955C2 (sr)
WO (1) WO1998052973A1 (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4912875B2 (ja) * 2004-02-27 2012-04-11 不二製油株式会社 癌転移抑制組成物
US8022216B2 (en) * 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
SI24318A (sl) 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
US10350293B2 (en) 2016-08-23 2019-07-16 Pharmacotherapia d.o.o. Compositions and methods for treating symptoms associated with multiple sclerosis
HUE066356T2 (hu) 2017-08-24 2024-07-28 Novo Nordisk As GLP-1 készítmények és alkalmazásaik
PE20221575A1 (es) 2020-02-18 2022-10-06 Novo Nordisk As Formulaciones farmaceuticas
US11065298B1 (en) * 2020-04-24 2021-07-20 Chanda Zaveri Compositions and methods for treating or preventing viral infections
US12605427B2 (en) * 2023-05-15 2026-04-21 Red Mountain Med Spa, LLC Sublingual semaglutide-BPC 157 combination for weight loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104704C1 (ru) * 1990-09-11 1998-02-20 Сикирич Предраг Фармакологически активная субстанция защитного соединения организма 3со, способ ее получения и терапевтическое применение
ATE152734T1 (de) * 1992-05-30 1997-05-15 Sikiric Predrag Bpc-peptide, deren herstellung und verwendung
RU2116311C1 (ru) 1992-11-16 1998-07-27 Сикирич Предраг Пептиды, обладающие органозащитной активностью, фармакологически активная композиция

Also Published As

Publication number Publication date
AU731317B2 (en) 2001-03-29
BR9809457B1 (pt) 2010-11-30
PL336897A1 (en) 2000-07-17
JP3492381B2 (ja) 2004-02-03
US6288028B1 (en) 2001-09-11
WO1998052973A1 (en) 1998-11-26
RS49733B (sr) 2008-04-04
EP0983300B1 (en) 2004-09-29
PL193790B1 (pl) 2007-03-30
JP2000515558A (ja) 2000-11-21
YU60199A (sh) 2002-09-19
AR011478A1 (es) 2000-08-16
CN1166683C (zh) 2004-09-15
DK0983300T3 (da) 2005-01-31
HUP0002329A3 (en) 2001-03-28
CZ299423B6 (cs) 2008-07-23
NZ501323A (en) 2001-04-27
BG103905A (en) 2000-07-31
TR199902866T2 (xx) 2000-02-21
NO321126B1 (no) 2006-03-20
IL132884A0 (en) 2001-03-19
SK159599A3 (en) 2000-11-07
CZ9904142A3 (cs) 2002-03-13
PT983300E (pt) 2005-02-28
HU227800B1 (en) 2012-03-28
ES2229507T3 (es) 2005-04-16
CA2290739A1 (en) 1998-11-26
CN1257510A (zh) 2000-06-21
EP0983300A1 (en) 2000-03-08
CA2290739C (en) 2007-06-26
EA199901061A1 (ru) 2000-06-26
UA61955C2 (en) 2003-12-15
BG64023B1 (bg) 2003-10-31
IL132884A (en) 2007-08-19
ATE277948T1 (de) 2004-10-15
DE69826653D1 (de) 2004-11-04
KR100488038B1 (ko) 2005-05-09
NO995692D0 (no) 1999-11-19
HUP0002329A1 (hu) 2000-12-28
BR9809457A (pt) 2000-06-20
DE69826653T2 (de) 2006-03-09
AU7914198A (en) 1998-12-11
KR20010012895A (ko) 2001-02-26
EA002058B1 (ru) 2001-12-24
NO995692L (no) 2000-01-24

Similar Documents

Publication Publication Date Title
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
TR200500221T2 (tr) Farmasötik Maddeler Olarak Bisiklik Amino Asitler
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
CY1109868T1 (el) Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
NZ333232A (en) Use of p-aminophenol derivatives (paracetamol) to treat neurodegenerative disease
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
TR200100637T2 (tr) Yeni doğal ürün türevleri
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
PT983300E (pt) Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
DE69721484D1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
BG101846A (bg) Варианти на човешка дезоксирибонуклеаза i
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten